Blackhawk Growth Corp
  • Home
  • About Us
  • Investors
      • Back
      • Stock Info
      • Capital Structure
      • Media
      • Corporate Presentation
      • Financial Statements
  • Investments
      • Back
      • Mindbio Therapeutics
      • Digital Mind Technologies
      • TERP Wholesale LLC
      • Trip Pharma
      • Sac Pharma
      • Spaced Food
      • Noble Hemp
      • Medigen + TBG
  • News
      • Back
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
  • Contact
banner blackh
 

NEWS RELEASES

CSE:BLR | Frankfurt: 0JJ | US-OTC:BLRZF

  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
Articles
Title Created Date
Blackhawk Growth's Spaced Food To Launch In Canada's Largest Market Dec 19
Blackhawk Growth Receives Court Approval to Hold Special Meeting on December 22nd 2022 to Approve Mindbio Therapeutics Spinout Dec 02
Blackhawk Growth Announces Shareholder Meeting for December 22, 2022 to Vote on the Spin-Out of Mindbio Therapeutics Nov 07
Blackhawk's Mindbio Reveals Positive Data From Phase 1 Randomised Double-Blind Placebo Controlled Clinical Trials Microdosing LSD In 80 Healthy Participants Nov 04
Blackhawk Growth to Reprofile Existing Credit Facility and Add Additional $2 Million Dollar Facility Oct 28
BLACKHAWK's Mindbio Announces Phase 2A/B Clinical Trials Microdosing LSD in Major Depressive Disorder Submitted for Ethics & Regulatory Approval Sep 28
BLACKHAWK's Mindbio Nominated for Company of the Year by Industry Peers as it Prepares for Phase 2 Clinical Trials Sep 22
Blackhawk's MindBio Therapeutics Announces Reveal Date for Presentation of Phase 1 Clinical Trial Data Sep 15
Blackhawk Growth's Spaced Food Manufacturing Partner Completes Development of Spaced Food Edibles; Prepares for Commercial Production Aug 29
Blackhawk Growth Sets AGM Date and Provides Corporate Update Aug 09
Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder Jul 25
Blackhawk's Terp Wholesale LLC Reports Unaudited Cdn$1,644,043 in Gross Revenue for First Five Months Ended May 31st, 2022 Jun 16
Blackhawk Appoints Justin Hanka as Chairman of The Board Jun 06
Blackhawk Growth Files Quarter Ended March 31, 2022 Financials and Reports Increase in Value of its Portfolio by 8.8% Quarter Over Quarter May 30
Blackhawk's Terp Wholesale LLC Expands Facility, Launches Retail Delivery May 24
Blackhawk's Mindbio Therapeutics Accelerates Global Communications Expansion Ahead of Phase 2 Clinical Trials May 11
Blackhawk's MindBio Therapeutics Announces Completion of World First Phase 1 Microdosing Clinical Trial May 03
Blackhawk Growth Closes Investment in Blum Distributors Apr 28
BLACKHAWK GROWTHS Blum Distributors Expands Facility and Starts to Fulfill Applied Myco Order Apr 19
BLACKHAWK GROWTH to Acquire Mycology Supplier and Cultivator - Blum Distributors Apr 06
Blackhawk's MindBio Therapeutics Enters its 80th and Final Patient into Phase 1 Clinical Trials and Provides Update for MindBio Spinout Apr 04
Blackhawk Growth's Spaced Food Adds New Flavours and Signs Partnership Agreement with Gaia Grow's Canadian Cannabis Laboratory Tru Extracts for Manufacturing of Blackhawk's Spaced Food Products Mar 31
Blackhawks Mindbio Therapeutics Announces Investment in Health Research Platform Quantified Citizen, a Health Technology Company Disrupting and Decentralizing Clinical Research Mar 15
Blackhawk Growth Closes Investment in Stable Foods Mar 11
Blackhawk's MindBio Therapeutics Invests NZ$2.3 Million to Fast Track Psychedelic Microdosing Phase 2 Clinical Trials Mar 10
Blackhawk's MindBio Therapeutics Announces Platinum Sponsorship of Plant Medicine Week in Malta Mar 08
Blackhawk Growth to Acquire Remaining 49% of NuWave Foods; NuWave Foods Changes Name to Stable Foods Feb 28
Blackhawk Subsidiary Digital Mind Technology Starts Phase 1 Development of Digital Therapeutic Platform and is on Track for Completion in Q2, 2022 Feb 17
Blackhawk Publishes MindBio Therapeutics Investor Presentation & Q&A Event on Website Feb 03
Blackhawk CEO Frederick Pels and MindBio Therapeutics Co-Founder Justin Hanka Will Lead Investor Presentation and Q&A Session Wednesday, February 2nd at 3pm Pacific Standard Time Feb 01
Blackhawk Launches New Website, Corporate Presentation and Engages Investor Relations Professional to Expand Outreach Jan 26
Blackhawk's MindBio Therapeutics Ahead of Schedule to Complete Phase 1 Clinical Trial Microdosing of Psychedelic Medicines and Provides Updates on Spinout Process Jan 24
Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder Jan 17
Blackhawk’s TERP Wholesale LLC Receives State-Issued Micro-Business License Allowing for Retail Delivery Jan 12
Blackhawk’s TERP Wholesale LLC Reports Unaudited $2,503,133 in Gross Revenue for Nine Months Ended September 30th, 2021 Jan 06
Blackhawk’s MindBio Therapeutics to Develop Proprietary Drug Delivery Technology for Psychedelic Medicines Jan 04
Blackhawk Growth Corp
  • Home
  • About Us
  • Investors
  • Investments
  • News
  • Contact
© Copyright - 2023 Blackhawk Growth Corp. | Website by Sandman Media Inc.